EDGAR Filing Documents for 0001640455-17-000050

Form 8-K - Current report:

SEC Accession No. 0001640455-17-000050

Filing Date

2017-11-13

Accepted

2017-11-13 07:16:09

Documents

Period of Report

2017-11-13

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	jnce093020178-k.htm	8-K	25433
2	EXHIBIT 99.1	jnce09302017exhibit991.htm	EX-99.1	121129
3		jouncelogosmaller.jpg	GRAPHIC	44678
	Complete submission text file	0001640455-17-000050.txt		209109

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139

Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840

Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 171193081
SIC: 2836 Biological Products, (No Diagnostic Substances)